APOE and infection: Recent work suggests that their beneficial role in infection control may inadvertently contribute to AD progression, and that neutrophil‐driven inflammation and immune regulation could represent novel therapeutic targets for AD.[40] The correlation between APOE alleles and this signature suggests that the role of e2 in modulating inflammatory response could be enacted in non‐e2 carriers by direct targeting of this signature.